Carnegie Investment Counsel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coinbase
COIN
|
+$18.7M |
| 2 |
GXO Logistics
GXO
|
+$15.8M |
| 3 |
Upstart Holdings
UPST
|
+$11.3M |
| 4 |
FuboTV Inc
FUBO
|
+$9.92M |
| 5 |
QuantumScape Corp
QS
|
+$8.23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COR
Coresite Realty Corporation
COR
|
+$7.7M |
| 2 |
Guardant Health
GH
|
+$6.34M |
| 3 |
Verizon
VZ
|
+$5.1M |
| 4 |
Arista Networks
ANET
|
+$2.89M |
| 5 |
Amgen
AMGN
|
+$2.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.53% |
| 2 | Financials | 13.58% |
| 3 | Healthcare | 10.36% |
| 4 | Industrials | 10.17% |
| 5 | Consumer Discretionary | 8.74% |
Similar funds
Carnegie Investment Counsel's Q4 2021 Portfolio in Review
As of Q4 2021, Carnegie Investment Counsel held 523 positions worth $3.03B, up 14% from $2.66B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Carnegie Investment Counsel deployed $203M of net new capital in Q4 2021, opening 55 new positions and adding to 245 existing holdings. Its largest new stake was Coinbase: 64,289 shares worth $16.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Guardant Health, an estimated $6.34M trimmed.
- Carnegie Investment Counsel's largest Q4 2021 buy was Coinbase: 64,289 shares worth $16.2M.
- Carnegie Investment Counsel added most to Upstart Holdings in Q4 2021, an estimated $11.3M increase.
- Carnegie Investment Counsel's biggest Q4 2021 reduction was Guardant Health, cutting an estimated $6.34M.
- Carnegie Investment Counsel fully exited Coresite Realty Corporation in Q4 2021, selling an estimated $7.7M.
- Carnegie Investment Counsel's ten largest holdings make up 21% of its $3.03B portfolio in Q4 2021.
- Carnegie Investment Counsel opened 55 new positions and closed 28 in Q4 2021.
- Carnegie Investment Counsel's portfolio value rose 14% quarter-over-quarter to $3.03B.
Based on Carnegie Investment Counsel's 13F filing for Q4 2021, filed 21 Jan 2022.